Severe Dyshidrotic Eczema after Intravenous Immunoglobulin Therapy for Kawasaki Syndrome.
Shiraishi, Takahisa M.D. 1; Yamamoto, Toshiyuki M.D. 1
[Report] Pediatric Dermatology. 30(3):e30-e31, May/June 2013.

(Format: HTML, PDF)

colon; Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.

Copyright (C) 2013 Blackwell Publishing Ltd.